Novo Nordisk Stock: Oral Wegovy Clocks 18,000 Prescriptions
Key Points:
- Investor’s Business Daily (IBD) provides information solely for informational and educational purposes and does not offer investment advice or recommendations.
- The data presented is sourced from what IBD believes are reliable sources, but accuracy, timeliness, or suitability cannot be guaranteed.
- Past investment performance cited by IBD does not predict or ensure future results, and authors may have personal stock holdings discussed in their content.
- Real-time price data is provided by Nasdaq Last Sale but may not cover all markets; ownership and estimate data come from LSEG and FactSet respectively.
- All trademarks mentioned are owned by Investor’s Business Daily, LLC, and all information is subject to change without prior notice.